This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The programme will take place on the 2nd Sunday of every month
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Announces Rs. 317 crore investment in new recycling plant
Overall investment in the US facility is estimated around US$50 million
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
Subscribe To Our Newsletter & Stay Updated
